These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2192875)
1. Role of circulating high-density lipoprotein and triglycerides in coronary artery disease: risk and prevention. Gordon DJ Endocrinol Metab Clin North Am; 1990 Jun; 19(2):299-309. PubMed ID: 2192875 [TBL] [Abstract][Full Text] [Related]
2. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913 [TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Gotto AM Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414 [TBL] [Abstract][Full Text] [Related]
4. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
5. Plasma triglyceride-rich lipoprotein and high density lipoproteins disorders associated with atherosclerosis. Genest J; Cohn J J Investig Med; 1998 Oct; 46(8):351-8. PubMed ID: 9805418 [TBL] [Abstract][Full Text] [Related]
6. An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets. McCarty MF Med Hypotheses; 2004; 63(6):1065-73. PubMed ID: 15504577 [TBL] [Abstract][Full Text] [Related]
7. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C. Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C; Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528 [TBL] [Abstract][Full Text] [Related]
8. Plasma high density lipoproteins and coronary artery disease. Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063 [TBL] [Abstract][Full Text] [Related]
9. [High triglyceride, low HDL-cholesterol and risk of coronary heart disease]. Jeppesen J; Madsbad S Ugeskr Laeger; 1996 Nov; 158(48):6896-901. PubMed ID: 8984751 [TBL] [Abstract][Full Text] [Related]
10. Lipid measurements for coronary risk assessment: a review. Berg LH Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628 [TBL] [Abstract][Full Text] [Related]
11. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease. Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036 [TBL] [Abstract][Full Text] [Related]
14. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932 [TBL] [Abstract][Full Text] [Related]
15. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels]. Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580 [TBL] [Abstract][Full Text] [Related]
16. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Bersot TP; Pépin GM; Mahley RW Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998 [TBL] [Abstract][Full Text] [Related]
17. Triglycerides and coronary risk in women and the elderly. LaRosa JC Arch Intern Med; 1997 May; 157(9):961-8. PubMed ID: 9140266 [TBL] [Abstract][Full Text] [Related]
18. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Assmann G; Schulte H; Funke H; von Eckardstein A Eur Heart J; 1998 Oct; 19 Suppl M():M8-14. PubMed ID: 9821011 [TBL] [Abstract][Full Text] [Related]
19. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides]. Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711 [TBL] [Abstract][Full Text] [Related]
20. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]